by Ben Best
Low-fat foods have frequently been advocated for people attempting to diet. Some people
on diets to lose weight have discovered that they can satisfy their appetite
with fewer calories by eating protein and carbohydrate instead of fat. Losing
weight not only makes a person look good, it can reduce the danger of
getting heart disease, diabetes and
cancer [*1]. But
the health hazards and benefits of fats, carbohydrates and proteins — and their
effectiveness for diets and dieting — depend greatly on the type
of fat, carbohydrate and protein.
(See Macronutrients, Dieting and Health)
Dietary fat by itself, not just the body fat it produces, can be a health hazard. A recent study has shown that reducing dietary fat from 36% of total calories to 26% of total calories can significantly lower blood pressure within 8 weeks [*2]. Saturated fat in the diet can increase the risk of heart disease from atherosclerosis (fatty plaques on blood vessel walls) by raising blood cholesterol. Unsaturated fat is more likely to form free radicals by lipid peroxidation — which can lead to cancer and may accelerate aging. Therefore, both saturated and unsaturated fat can have health hazards. But every cell membrane in the body contains fat, and some of those fats cannot by synthesized — making it essential to obtain these fats from diet.
Some nutritionists have recommended substituting mono-unsaturated and poly-unsaturated fats for saturated fats, but another recommendation is to substitute protein and carbohydrate calories for fat calories [*3]. Fats (especially animal fats) are the primary vehicle by which pesticides enter the body. Some people might conclude that it would be a good idea to eliminate all fat from the diet. But eliminating all fat is not a good idea.
Your body needs fats to function properly. Nearly half of the dry weight of the brain is fat, and a quarter of this is cholesterol. Cholesterol is an essential part of sex hormones, bile acids, D vitamins and steroid hormones from the cortex of the adrenal gland — among other important substances. Cholesterol does not need to be eaten, however, because the liver and other tissues can manufacture cholesterol from saturated fats. But too many saturated fats result in excessively high blood levels of cholesterol that can end up being deposited in atherosclerotic plaques on blood vessels, leading to cardiovascular disease. High blood cholesterol also depresses the immune system and thereby increases the incidence of cancer [*4]. Excessive blood cholesterol is more often caused by eating too many saturated fats than by eating cholesterol itself.
Studies in the United States and Northern Europe have established that the incidence of coronary heart disease mortality is nearly two-and-a-half times higher for people with the highest 25% of blood cholesterol compared with people with the lowest 25%. Yet the coronary heart disease mortality for the same cholesterol levels is only one-third as great in Japan or the Mediterranean [*6]. A person in west Scotland having the same blood cholesterol levels as a person in Catalonia, Spain is 8-times more likely to die of coronary heart disease. So although cholesterol is a factor in coronary mortality, it is not the only factor.
The term blood cholesterol is actually a reference to HDL (High-Density Lipoprotein), LDL (Low-Density Lipoprotein) and VLDL (Very Low-Density Lipoprotein). "Lipo" means "lipid", a general term that refers to all biological fats and oils. HDL has been called "good cholesterol" because it can pick up excess fats and carry them back to the liver. LDL (and especially VLDL) has been called "bad cholesterol" because it can become so overloaded with fats that the fats are dropped on blood vessel walls rather than carried to the cells where they are needed. LDL could also be called "good", because LDL supplies cells with fats needed for structure and function. In fact, LDL is the main carrier of oil-soluble substances (like Vitamin E) to body cells [*5]. LDL-cholesterol is just HDL-cholesterol with a larger load of surrounding fat. Exercise creates HDL from LDL by removing fat from LDL for use as energy.
Oxidation of LDL is what causes cholesterol to be deposited in plaque on blood vessel walls [*5]. The vulnerability of LDL cholesterol to oxidation depends on both the quantity of antioxidants in the blood and on the type of fatty acid in the LDL. Fruits, vegetables and supplements (especially Vitamin E with Vitamin C) will reduce LDL oxidation. The dietary fat that is most vulnerable to oxidation is linoleic acid [*7]. High blood levels of homocysteine thiolactone cause LDL to aggregate. Oxidized, aggregated LDL is readily attacked by macrophages to form atherosclerotic plaques on blood vessel walls [*8].
Aside from cholesterol, most other fat in the body is constructed from what is known as fatty acids. A fatty acid is a long straight chain of carbon atoms (studded with hydrogen atoms) that has an acid group (carboxylic acid) at one end (the water-soluble end). The rest of the fatty acid is oil-soluble, with a methyl group at the other end. Fatty acids in the body usually exist unattached to any other molecule (free fatty acids), attached to glycerol in groups of three (triglycerides), or attached to phosphatidic acid molecules (phospholipids).
Fatty acids differ from one another not only by the number of carbons in their chain, but by the number of double-bonds between the carbon atoms. Fatty acids with only single-bonds are called saturated because they are "saturated" with as many hydrogen atoms as they can carry. Fatty acids with only one double-bond are called mono-unsaturated. And fatty acids with more than one double-bond are called poly-unsaturated.
Polyunsaturated fats have often been recommended to reduce coronary heart disease [*9]. But all saturated fats do not have the same effect on cholesterol synthesis in the liver. Only the saturated fats of chain-length 12, 14 and 16 (lauric acid, myristic acid and palmitic acid) have been shown to elevate blood cholesterol. Of these, myristic acid (high in coconut and palm oil) elevates cholesterol the most [*10]. Stearic acid (18-carbon, saturated) has been shown to lower cholesterol by 21% — even more than oleic acid (18-carbon, mono-unsaturated) which lowers LDL by 15% [*11].


Polyunsaturated fatty acids can be a health hazard because carbon-carbon double bonds can lead to free-radical formation and reactions with oxygen to form unstable lipid peroxide compounds containing the same unstable oxygen-oxygen bond found in hydrogen peroxide. Lipid peroxidation and free radicals can cause cancer and may accelerate aging. High rates of lung cancer among women in China have been associated with lipid peroxidized oils in fumes from cooking polyunsaturated vegetable oils in a wok [*12]. Hot oil in open air is subject to much lipid peroxidation. Fast-food restaurants that fry foods in the same oil all day serve lots of lipid peroxides to their customers.
Polyunsaturated "cis" fatty acids can be beneficial in cell membranes by preventing the tight packing of fatty acids in membranes — thereby making the membranes more "fluid". Membrane fluidity is important for optimal function of most cells in the body. But membrane fluidity is especially important on portions of cells that act as receptors for hormones or neurotransmitters. The typical North American eats three times as much saturated fat as unsaturated fat, yet animal experiments show that insulin receptor responsiveness is substantially improved when dietary unsaturated fat is greater than saturated fat [*13]. With aging, however, cell membrane fluidity declines in part because of increasing amount of cholesterol in the membranes, but more importantly because of free-radical oxidation [*14]. Antioxidants that protect cell membranes, like Vitamin E, are extremely valuable in opposing membrane oxidation.
| CIS ISOMER | TRANS ISOMER |
|---|---|
|
|
Fatty acid double-bonds come in two configurations known as cis (carbon chains on the same side of a double-bond) and trans (carbon chains on the opposite side of a double-bond). Most of the double-bonds made by biological systems have the cis configuration. It is the cis configuration of unsaturated fatty acids that prevents tight packing of fatty acids in membranes, and hence increases membrane fluidity.
Saturated fats (like butter or lard) and fatty acids with trans double-bonds (like margarine) tend to be solids at room temperature, whereas natural fatty acids with cis double-bonds (like vegetable oils) tend to be liquids. By artificially hydrogenating vegetable oils, the food processing industry reduces the number of double bonds and causes the formation of trans fatty acids. Hydrogenation results in margarines that are more solid and less vulnerable to rancidity. Hydrogenation results in peanut butter with a trans-fat-containing oil that does not separate from the peanut paste. But when trans fatty acids are incorporated into cell membranes, the membrane fluidity is reduced and the cells do not function as well. Not all trans fatty acids in the diet are due to food processing. For example, natural butter is 5% trans fat.

The human body can manufacture most of the fats it needs, including cholesterol, saturated fatty acids and unsaturated fatty acids. But there are two fatty acids which cannot be manufactured in the body, and which must be obtained from dietary sources: linoleic acid and alpha-linolenic acid. These are the essential fatty acids. Linoleic acid is an 18-carbon chain with 2 double-bonds, whereas alpha-linolenic acid is an 18-carbon chain with 3 double-bonds. The position of double-bonds in a fatty acid is critical to function, and this is especially true of double-bonds close to the methyl end. For long-chain fatty acids, the body's enzymes cannot add double-bonds near the methyl end.
A fatty acid has a carboxylic acid at one end and a methyl group at the other end. Carbon atoms in a fatty acid are identified by Greek letter on the basis of their distance from the carboxylic acid. The carbon atom closest to the to the carboxylic acid is the alpha (α) carbon, the next adjacent carbon is the beta (β) carbon, etc. In a long-chain fatty acid the carbon atom in the methyl group is called the omega (ω) carbon because omega is the last letter of the Greek alphabet. Because the closest double-bond to the methyl group in linoleic acid is 6 carbon atoms away from the methyl, linoleic acid is called an omega−6 (ω−6 or n−6) fatty acid. For alpha-linolenic acid, the double-bond closest to the methyl group is only 3 carbons away, so it is an omega−3 (ω−3 or n−3) ) fatty acid. The carbon next to the carboxylic acid is called the alpha carbon because alpha is the first letter of the Greek alphabet. But to confuse matters, the acid end of a fatty acid is called the delta (δ) end.
The configuration (geometry) at the double bond can be either
cis (adjacent hydrogen atoms on the same side of
the molecule) or trans (adjacent atoms on the opposite side).
Unsaturated fatty acids in the trans configuration are more
linear, more rigid and have a higher melting-point. The distinctiveness
of cis & trans fatty acids merit
unique names: cis-9-octadecanoic acid is oleic acid,
whereas trans-9-octadecanoic acid is elaidic acid.
(For more on trans fatty acids, see my essay
Are Trans-Fatty Acids a Health Hazard?.)


The body cannot make an omega−3 or omega−6 fatty acid because human metabolism cannot add a double-bond to a fatty acid that is more than 9 carbons away from the delta end. For the same reason, the body cannot convert an omega−3 to an omega−6 fatty acid, or vice-versa. But the body can make omega−9 fatty acids. And the body can add more double-bonds closer to the delta end of omega−3 and omega−6 fatty acids.
Two distinct families of essential fatty acids exist in the human
body: the omega−3 family and omega−6 family. The omega−3 family comes from
alpha-linolenic acid, and the omega−6 family comes from linoleic acid.
Each family is the result of increasing chain length and of forming
double-bonds from one of these two essential fatty acids. The two families
compete for the same enzymes
for forming double bonds (desaturase enzymes) and enzymes for lengthening
the carbon chain (elongase enzymes). Elongase enzymes always add
carbon atoms (in pairs) to the delta end of the fatty acid.
|
Forming a double-bond at the 9th carbon of linoleic acid results
in gamma-linolenic acid (GLA). Like alpha-linolenic acid, gamma-linolenic
acid has 3 double-bonds. But gamma-linolenic acid is an omega−6, whereas
alpha-linolenic is an omega−3 fatty acid. The words "alpha" and "gamma"
in this case
have no chemical meaning. The confusing terms "alpha-linolenic" and
"gamma-linolenic" are common names, not scientific names, and
are meaningless in the context of current scientific naming conventions.

Another important product of linoleic acid is arachidonic acid. Arachidonic acid is a 20-carbon omega−6 fatty acid with 4 double-bonds. Arachidonic acid, in turn, gives rise to a whole group of 20-carbon, biologically-important substances known as the eicosanoids (eicosa- is Greek for "20"), including prostaglandins, thromboxanes, lipoxins and leukotrienes — which affect immunity, inflammation and blood clotting (among other actions). But omega−3 fatty acids can also produce eicosanoids.
Noteworthy members of the omega−3 family of fatty acids manufactured from alpha-linolenic acid are EicosaPentaenoic Acid (EPA) and DocasaHexaenoic Acid (DHA). A pentaenoic acid has 5 double-bonds. A hexaenoic acid has 6 double-bonds. EPA is a 20-carbon chain fatty acid, whereas DHA is a 22-carbon chain fatty acid. Like arachidonic acid, EPA gives rise to its own class of eicosanoids. The EPA-generated eicosanoids are in the omega−3 family, as distinct from the omega−6 eicosanoids derived from arachidonic acid.

The primary source of omega−6 fatty acids in the diet is linoleic acid from the oils of seeds and grains. Sunflower, safflower and corn oil are particularly rich sources of linoleic acid, which is at the root of the omega−6 fatty-acid family. Evening primrose oil and borage oil are high not only in linoleic acid, but the omega−6 derivative gamma-linolenic acid (GLA). Avocado is 15-20% oil — mainly monosaturated, but also high in linoleic acid. (Avocado has the highest fat content and the highest fiber content — soluble as well as insoluble — of any fruit.)

Alpha-linolenic acid, the primary dietary source of omega−3 fatty acids in the diet, is frequently found in green leaves. The leaves and seeds of the perilla plant (widely eaten in Japan, Korea and India) are the richest plant source of alpha-linolenic acid, although linseed oil is also a rich source. Fish oil contains very little alpha-linolenic acid, but is rich in the omega−3 derivatives EPA and DHA. Fish are at the top of a food chain based on phytoplankton (algae) that manufacture large amounts of EPA and DHA. Nonetheless, fish can be high in toxic methylmercury. (For more information, see my essay Is Mercury in Fish a Health Hazard?)
It has been estimated that thousands of years ago the diet of human hunter-gatherers consisted of approximately equal parts of omega−3 and omega−6 essential fatty acids [*15]. Since the beginning of agriculture ten thousand years ago there has been a steady increase in omega−6 at the expense of omega−3 fat in the human diet. This process accelerated about 50 years ago as cattle began to be fed increasingly on grains rather than grass. Recommendations by nutritionists to eat margarine rather than butter (polyunsaturated rather than saturated fats) increased the trend toward omega−6 and trans fat consumption. Currently, the ratio of omega−6 to omega−3 fatty acids in the American diet is 7−to−1 or more. There are good reasons to believe that this imbalanced essential fatty acid ratio has led to increased cancer, heart disease, allergies, diabetes and other afflictions. Much of the reason for this lies in the membranes of our cells.
Phospholipids and cholesterol are the principal components of nearly all
cell membranes. The backbone of a phospholipid is the same glycerol molecule
that forms the backbone of triglycerides. But instead of 3 fatty acids attached
to glycerol, a phospholipid consists of 2 fatty acids, a phosphate group
and an alcohol. The
most common alcohols are derived from serine, ethanolamine, choline and
inositol. Thus, the most common phospholipids are
phosphatidylcholine, phospatidylethanolamine,
phosphatidylserine, and phosphatidylinositol.
Phosphatidylcholine is also known as lecithin.
"Commercial lecithin" (which is used as an emulsifying agent in food
processing) is a mixture of phospholipids from eggs, soybeans, nuts, etc.,
with phosphatidylcholine as the major ingredient.
|
Different cells have different quantities of phospholipid in their membranes. Gray matter in the brain is nearly 70% phospholipid, whereas brain white matter is less than half phospholipid because of high concentrations of glycolipid (sugar-fat). There is much variation in the amounts and kinds of phospholipid in membranes. Brain gray matter is 30% phosphatidylcholine whereas brain white matter is 10% phosphatidylcholine. The inner layer of neuron membranes primarily contain phosphatidylethanolamine & phosphatidylserine, whereas in the outer layer phosphatidylcholine & sphingomyelin predominate.
Mitochondrial and endoplasmic reticulum membranes are both 40% phosphatidylcholine. But mitochondrial membranes are also 35% phosphatidylethanolamine, whereas endoplasmic reticulum membrane is about 17% phosphatidylethanolamine.
Cells also vary considerably in the kinds of fatty acids attached to phosphatidic acid. In gray matter cell membranes, the fatty acids in the middle position of phospholipids are composed of carbon chains that are longer and more unsaturated than fatty acids found in the membrane phospholipids of most other cells. Fatty acids that are long and highly unsaturated increase membrane fluidity and functionality, which is why DHA and arachidonic acid are highly concentrated in the phospholipids of neuron synapses. Unsaturated fatty acids are also important for membrane activity at the site of hormone receptors. Insulin resistance in adult-onset diabetes is associated with fewer membrane long-chain unsaturated fatty acids due to impaired desaturase and elongase enzyme function [*16].
The alcohol portion of a phospholipid protrudes away from the
membrane, whereas the two fatty acids jut into the membrane. The
middle fatty acid (in the second position) is usually unsaturated
(like DHA or arachidonic acid) whereas the end fatty acid (in the
first position) is usually saturated (like stearic acid). Each of
the 3 groups attached to the glycerol backbone has a special enzyme
that can separate the group from the backbone.
Phospholipase A1
enzyme attacks the attachment of the first fatty acid,
Phospholipase A2
attacks the attachment of the middle fatty acid and
Phospholipase D attacks the alcohol attachment.
Phospholipase C — which is a major toxin secreted by bacteria —
releases 1,2-DiAcylGlycerol (DAG) along with a phosphoryl base.
|
Frequently the unsaturated fatty acid stored in the second position of a cell membrane will be arachidonic acid, EPA or DHA (especially in the neurons). The release of arachidonic acid or EPA from cell membranes by Phospholipase A2 allows the enzymes lipoxygenase and cyclooxygenase to form biologically active eicosanoids like prostaglandins (PGZs, first isolated in prostate gland), thromboxanes (TXZs, first isolated in thrombocytes) and leucotrienes (LTZs, first isolated in leucocytes). These eicosanoids can be compared to hormones, except that unlike hormones they are destroyed by local enzymes within seconds or minutes after formation. This limits the activities of eicosanoids to the area where they were released.
Having cell membranes contain fatty acids that can form the
hormone-like eicosanoids gives the body the capacity to produce quick,
localized action in almost any tissue or organ. The most general need
for rapid, local action is the response to trauma. Therefore, eicosanoids are most often
concerned with clotting, inflammation and the initiation of immune defense.
Some membrane phospholipids, such as the phosphatidylinositols, function to convert activity at cell surface G-protein-coupled receptors into intracellular signals. Hydrolysis by phospholipase C and phospholipase D produce the second messengers (intracellular messengers) DiAcylGlycerol (DAG) [which stimulates Protein Kinase C (PKC)] and Inositol triPhosphate (IP3) [which causes intracellular release of calcium]. Activated PKC concentrates in the plasma membrane where it phosphorylates membrane proteins of receptors and ion-channels to inhibit their function (negative feedback). Nuclear Factor kappaB (NF−κB) activated by PKC binds to DNA promoters & enhancers of inflammatory cytokines, among other genes. IP3 binds to the endoplasmic reticulum, releasing calcium stored in that location. DAG can be further hydrolysed by Phospholipase A2 to release more arachidonic acid. Ethanol increases Phospholipase A2 activity, increasing oxidative stress.
Three categories of PhosphoLipase A2 (PLA2) are recognized: secretory PLA2 (sPLA2), cytoplasmic PLA2 (cPLA2) and Ca2+-independent PLA2 (iPLA2). The cPLA2 is activated by Ca2+ to a much greater extent than sPLA2. Whereas sPLA2 is more prominent in inflammatory disease, cPLA2 is more associated with oxidative free radical damage. The cPLA2 shows a marked preference for hydrolyzing oxidized arachidonic acid in cell membranes, which may be important for membrane maintenance when sufficient ATP is available to synthesize and insert fresh arachidonic acid into membranes. Arachidonic acid is a particularly common constituent of brain neuron membranes and the massive release of arachidonic acid in cerebral cortex ischemia/reperfusion plays a significant role in exacerbating ischemic/reperfusion damage. The activity of cPLA2 on inner mitochondrial membranes can also be exacerbated under conditions of high oxidative stress.
There are three series of the prostaglandin and thromboxane
eicosanoids: one derived from DGLA (series 1), one derived from arachidonic
acid (series 2) and one derived from EPA (series 3). The series number
indicates the number of double-bonds in the prostaglandin or thromboxane.
Series 1 prostaglandins are not as common in the body as
series 2 or 3 — in part because DGLA is not plentiful in many tissues.
Series 2 predominates over series 3 for at least three
reasons: (1) arachidonic
acid is more readily released from cell membranes than EPA, (2) arachidonic
acid reacts far more avidly with cyclo-oxygenase enzyme than does EPA and
(3) contemporary Western diets contain large amount of linoleic acid, which
results in large amounts of arachidonic acid in cell membranes. The
predominance of arachidonic acid eicosanoids over EPA-eicosanoids due to
excessively high dietary omega−6 (compared to omega−3) is at the root of
many modern health problems, only some of which are concerned with the immune
system.
|
|
|
Cyclooxygenases (COXs) can be divided into COX-1 (present at constant levels in most cells & tissues) and COX-2 (normally absent from most cells, but rapidly rising to high levels in response to growth factors, cytokines, hypoxia, toxins and other stimuli). COX-1 is regarded as a "housekeeping" enzyme responsible for such functions as maintaining gastrointestinal mucosal integrity and regulation of kidney blood flow. COX-2 expression in response to inflammation & mitogens may lead to cancer. COX-2 enhances the formation of prostaglandins that mediate pain & inflammation. The attempts to create drugs that specifically inhibit COX-2 without inhibiting COX-1 (which can result in gastrointestinal bleeding) is based on this simplification [BIOCHEMICAL PHARMACOLOGY 65:153-159 (2003)].
Unlike COXs, which are active in most body cells, lipogenase enzyme is primarily
active in cells of the immune system. Lipogenase creates hydroperoxides from polyunsaturated
fatty acids by an insertion of molecular oxygen.
Both arachidonic acid (omega−6) and EPA (omega−3) can be acted-on by
lipoxygenase enzyme, rather than by cyclooxygenase — resulting in
leucotrienes (LTZs) rather than the prostaglandins (PGZs)
& thromboxanes (TXZs) produced by cycloxoygenase. Lipoxygenase produces
series 4 leucotrienes from arachidonic acid or series 5 leucotrienes from
EicosaPentoic Acid (EPA). Lipoxygenase is primarily found in granulocytes.
HydroxyPeroxyEicosaTetraEnoates (HPETEs)
are reactive hydroperoxides which can contribute to cellular damage in
atherosclerosis [THE JOURNAL OF CLINICAL INVESTIGATION 111(8):1107-1113(2003)].
HPETEs like other organic hydroperoxides (ROOH) can lead to lipid peroxidation
by Fenton-like reactions.
|
|
Arachidonic acid oxidized in the membranes of neurons which has been subsequently
liberated by phospholipase results in enzymatic products known as isoeicosanoids
because they are isomers of normal eicosanoids. Isoprostanes (isomers of
cyclooxygenase-derived prostaglandins) and particularly F2-isoprostanes
(isomers of prostaglandin F2α) have attracted special interest because they
are chemically stable and can be sensitively measured using mass spectrometry.
F2-isoprostanes have been used to quantify lipid peroxidation in atherosclerotic
plaques, in the brains of Alzheimer's
Disease patients and in the urine of smokers & myocardial infarction patients.
Elevated levels of F2α in pericaridial fluid is correlated with severity of heart
failure [CIRCULATION; Mallat,Z; 97(16):1536-1539 (1998)].
Analogous F-ring oxidized isomers of DHA breakdown products known as
F4-neuroprostanes have been isolated in elevated quantity in both
cerebrospinal fluid and brain tissue of Alzheimer's Disease patients [CELLULAR
AND MOLECULAR LIFE SCIENCES 59:808-820 (2002)].
Cell membrane enzyme activity is significantly influenced by membrane
fatty acid composition. Rats fed unsaturated fats show higher
sodium-potassium pump activity than rats fed
saturated fats [NEUROCHEMISTRY INTERNATIONAL; Srinivasarao,P; 31(6):789-794 (1997)].
Increasing membrane DHA content is a mechanism for cold adaptation in fish. But the
longer lifespan of birds compared to similar-sized mammals is attributed
to greater saturated fat content in membranes (lower
peroxidizability) [JOURNAL OF EXPERIMENTAL BIOLOGY; Hulbert,AJ;
206(Pt 14):2303-2311 (2003)].
One very general way of classifying immunity is to distinguish
between acquired immunity and innate immunity. Both systems make use of
phagocytes (cells that "eat" foreign substances) and antibodies (Y-shaped
chains of proteins known as immunoglobulins). Acquired immunity is
seen when the immune system has identified a foreign protein as being
an antigen. For innate immunity, however, there is a generalized reaction
against tissue trauma and infectious agents that could as easily be
described as inflammation as immunity. The swelling of inflammation
is associated with immunoglobulin-E (IgE) and with an increased blood
vessel permeability which allows Natural Killer cells, macrophages and
neutrophils to leave the blood stream, migrate to the injured area
and engulf the invaders. Although innate immune defense is not very
specific, it is rapid. By contrast, the immune cells (lymphocytes) and
immunoglobulins (IgM and IgG) of acquired immunity are slower to
develop, but can be very powerful and very specific against antigens.
The eicosanoids produced from arachidonic acid cause a stronger
inflammatory response than the eicosanoids from EPA or DGLA. The
arachidonic acid products LeukoTriene B4 (LTB4) and
ProstaGlandin E2 (PGE2) are powerful promoters of inflammation.
LTB4 is only formed in granulocytes subject to stimuli favoring action
by 5-lipoxygenase activating protein [ARCHIVES OF BIOCHEMISTRY AND PHYSICS
356(1):71-76 (1998)]. Both PGE2 & LTB4 increases tissue
swelling (edema) by making the vascular endothelium more leaky. LTB4
stimulates superoxide production by neutrophils, activates Natural Killer cells
and powerfully attracts inflammatory leukocytes. PGE2 increases
sensitivity to pain, raises temperature and increases the formation of
the allergic antibody Immunoglobulin E (IgE) [*17]. Aspirin irreversibly
blocks the enzyme cyclo-oxygenase, which prevents arachidonic acid from
being converted to prostaglandin — thereby limiting inflammation and pain.
Gamma-tocopherol (the major form of
Vitamin E in food, in contrast
to alpha-tocopherol, which is the major form of Vitamin E in supplement pills) also
blocks cyclo-oxygenase and reduces proinflammatory PGE2 & LTB4
formation [FASEB JOURNAL 17:816-822 (2003)].
Elevated body temperature, increased sensitivity to pain, inflammation
and allergic reactions are important body defense mechanisms. Inflammation
reduces the spread of infection. Elevated body temperature can kill bacteria
and viruses. Increased sensitivity to pain reduces movement of injured
body parts, preventing injury from getting worse. But when taken to
an extreme, inflammatory reactions can
result in auto-immune disease, septic shock, asthma and even fatal
anaphylactic shock. Chronic inflammation of the pancreas, colon and other organs
increase the risk of cancer
in those organs. The increasing incidence of allergies and seasonal
asthmas in modern society has been attributed to increased levels of the
arachidonic acid
eicosanoid LTB4 due to excessively high dietary omega−6 intake
relative to omega−3 [*18].
Gamma-Linolenic Acid (GLA) has been shown to be effective against
the inflammation of rheumatoid arthritis in a number of studies. Although
one might expect that GLA could lead to the formation of arachidonic acid's
pro-inflammatory eicosanoids, there is instead a production of the
anti-inflammatory prostaglandin PGE1 of the
1−series [*19,*20]. It may be that rheumatoid arthritis patients
suffer from impaired function of desaturase enzymes, preventing arachidonic
acid formation. In ulcerative colitis, an inflammatory condition in which
desaturase enzymes are normal, both omega−3 oils from fish and perilla
have been used for treatment [*21].
Feeding laboratory animals diets rich in omega−3 fatty acids (linseed
or fish oil) reduces Natural Killer cell and cytotoxic T−lymphocyte
activity [*22], but stimulates the more antigen-specific immunoglobulins
IgM and IgG [*17]. Innate immune response, although closely tied to
inflammation can be separated from inflammation to some extent. One
experiment showed that both fish oil and safflower oil reduced the secretion
of Interleukin-6 (a cytokine that activates lymphocyte immune-cells and
increases antibody production), but that only fish oil inhibited the
secretion of Tumor Necrosis Factor alpha (a cytokine that increases fever,
shock and blood vessel permeability) [*23].
As a first-line defense against infection, the
inflammatory/innate-immunity response can sometimes mean the difference
between life and death. Adding fish oil (which contains both DHA and EPA) to
the diet of rats increased the likelihood that the rats would die when
subjected to bacterial infection [*24]. Mixtures of DHA
and EPA strongly reduce Natural
Killer and Lymphocyte Activated cells [*25]. But immune suppression
appears to be more due to EPA than to DHA [*22]. In fact, when total fat
intake is low, DHA shows no inhibition of immune system function, even
though about 9% of DHA is converted back to EPA [*26]. The omega−6 to
omega−3 proportions may also determine immune suppression.
An experiment, using a mixture
of safflower oil and fish oil showed no immunosuppressive effect in rats
when the omega−6 to omega−3 ratio was approximately 2−to−1 [*23].
Cells of the immune system (like T-Cells, B-Cells and Macrophages)
have membranes that are particularly rich in long-chain
unsaturated fatty acids (such as arachidonic acid or EPA). Unlike
prostaglandins, which are formed from most cells of the body, leukotrienes
are made predominantly by polymorphonucleocytic leucocytes, macrophages
and mast cells.
Because immune system cells are so rich in arachidonic acid and EPA (and
also because of their mobility and functions) immune system cells are more
vulnerable to
free-radical oxidation than other cells. The nutrients that
most profoundly improve immune function are vitamin C,
vitamin E, selenium,
glutathione and zinc [*27]. All of these nutrients
are antioxidants,
although zinc's effects are more due to direct actions
on immune cell function than due to its anti-oxidant properties [*28].
Vitamin E opposes some, but
not all of the increased lipid peroxidation and immune suppression seen in
essential fatty acid supplementation [*29]. Vitamin E promotes immune function
by reducing PGE2 synthesis and thus increasing T-cell proliferation, IL-2
production and antibody production, while reducing IL-6 production. By scavenging
the hydroperoxide necessary for COX activity, Vitamin E opposes the increase
in PGE2 formation that is typically seen in
aging [AMERICAN JOURNAL OF PHYSIOLOGY; Wu,D;
275(3 Pt 1):C661-C668 (1998)]. PGE2 is known to
suppress lymphocyte proliferation, to suppress synthesis of chemical
factors (lymphokines) influencing the immune system and to contribute
to the auto-immune diseases that increase with aging [*30].
High fat diets are well-known to be associated with certain kinds
of cancers, including breast cancer, in particular [*31]. Although
butterfat stimulates breast cancer when compared with a fat-free diet,
safflower oil margarine (linoleic acid, an omega−6) has been shown to
induce breast
cancer much more strongly [*6]. Linoleic acid is the fat that most
frequently is associated with cancer, whereas omega−3 fatty acids like
DHA and perilla-oil suppress cancer [*32,*33]. It has been theorized that
linoleic acid causes cancer by chronic overproduction of the inflammatory
arachidonic acid eicosanoids, which stimulate the proliferation of
mutated cells [*6]. Omega−3 fatty acids reduce cancer risk by
markedly inhibiting
Activator Protein 1 (AP−1), a transcription factor
which promotes cancerous proliferation and metastasis. Omega−6
fatty acids promote cancer by blocking omega−3
activity [PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES (USA); Liu,G;
98(13): 7510-7515 (2001)].
PGE2 resulting from COX-2 enzyme is found in high levels in
colorectal carcinomas where the prostaglandin promotes growth through
transactivation of epithelial growth factor receptor signalling. PGE2
also induces expression of Vascular Endothelial Growth Factor (VEGF) in
colon cancer cells, resulting in the neoangiogenesis (new blood vessels) required
by growing tumors [JOURNAL OF CLINICAL INVESTIGATION; Williams,CS; 105(11):1589-1594 (2000)].
Nitric oxide is a regulator of COX-2 expression in the colon, and the phytochemical
curcumin (an
inhibitor of inducible nitric oxide synthetase found in curry) has been shown to reduce
pre-cancerous colon lesions by
45% [CARCINOGENESIS; Rao,CV; 20(4):641-644 (1999)].
Although too much linoleic acid can increase the risk of cancer,
a form of
linoleic acid in which the double-bonds are closer together — known
as Conjugated Linoleic Acid (CLA) — actually reduces cancer risk.
CLA has been shown to significantly inhibit
prostate cancer proliferation [*34] and breast cancer formation [*35] in
experimental animals. Large quantities of CLA are not needed since the
maximum anti-cancer effect is seen when CLA is
no more than 1% of calories. There is controversy over whether CLA is an
anti-oxidant.
Some researchers who believe that CLA is not an anti-oxidant
believe that CLA's effects are due to its blockage of arachidonic acid
formation [*36,*37].
CLA has also been shown to reduce atherosclerosis in rabbits [*38]. The best
dietary sources of CLA are the food products of ruminant animals
(ie, animals that "ruminate" their food by chewing a cud, like cows or deer),
such as beef, milk, yoghurt and cheese.
For technical details about the nature of cancer (and
methods of prevention) — see my essay
Cancer.
Insulin stimulates the delta−6−desaturase enzyme. Therefore, this
enzyme's activity is much reduced in diabetes. Reduced delta-6-desaturase
activity affects the omega−6 products significantly more than the
omega−3 products [*39]. Although excessive arachidonic acid is associated
with many modern illnesses, diabetics suffer from the effects of too little
arachidonic acid. Arachidonic acid is essential for leucocyte (white blood
cell) function. Reduced leucocyte function makes diabetics more
vulnerable to infection [*40].
Arachidonic acid deficiency in diabetics also reduces the activity
of the "sodium pump", slowing nerve conduction velocity and ultimately
leading to neuropathy (diseased nerves) [*41]. Insulin is the best
treatment for these arachidonic acid deficiency conditions, but gamma-linolenic
acid (GLA) also restores function. GLA bypasses the delta-6-desaturase step
in arachidonic acid synthesis. Evening primrose oil is the most effective
omega−6 treatment for diabetic neuropathy, despite the fact that borage oil
has more GLA. Although fish oil can be somewhat
beneficial when used alone, fish oil can detract from the effectiveness of
evening primrose oil when they are used in combination [*42].
Alcoholics
suffer from disturbances of fat metabolism, notably in
the liver. The liver is the most active site of delta-6-desaturase activity
in the body. In fact, many (if not most) cells in the body have no
delta-6-desaturase enzymes and are dependent upon the liver for omega−3/omega−6
desaturase/elongase products. Neuropathy and other conditions resulting from
desaturase dysfunction in alcoholics are benefitted by both evening primrose
oil and fish oil in combination [*43]. Arachidonic acid deficiency is
the most serious problem for alcoholics, however, so evening primrose oil
seems to be the best therapy [*44].
DHA and arachidonic acid are the predominant essential fatty acids
in the human brain. Neurons cannot synthesize arachidonic acid, but
astrocytes and cerebral epithelial cells have enzymes that can.
The ability of enzymes to produce the omega−6 and omega−3 family of
products of linoleic and alpha-linolenic acid declines with age. One
experiment showed that desaturase enzyme function in old rats was only
44% of the desaturase function in young rats [*39]. This decline in
desaturase activity has
provided a rationale for supplementation with GLA (bypassing
the delta-6-desaturase enzyme), and for supplementation with the
omega−3 products EPA and DHA. Fatty acids in human gray matter
phosphatidylethanolamine is roughly 25% DHA, 25% stearic acid,
14% arachidonic and 12% oleic acid. In the outer segments of retina
photo-receptors of the eye, DHA accounts for more than 50% of the fatty acid
content, probably because of the high membrane fluidity required for
sensitivity to light.
In the last third of pregnancy, and in the first four months
after birth, rapid brain growth in the human infant requires large amounts
of omega−3 and omega−6 essential fatty acids. Human milk
contains (in total fatty acids by weight) 12% linoleic acid,
0.5% alpha-linolenic acid, 0.6% arachidonic acid and 0.3% DHA [*45]. Infant
formulas frequently have not contained arachidonic acid or DHA. One study
showed that by (or just before) age 8, children who had been breast-fed as
infants had an 8.3-point IQ advantage over
children who had received formula [*46]. The study corrected for the
education and social class of the mother.
Support for the idea that DHA is critical for brain development
came from an experiment which
studied the effects of adding DHA (in the form of fish oil) to infant
formula. At both 16 and 30 weeks of age the breast-fed and
supplement-formula-fed infants showed significantly better visual acuity
than the placebo-formula-fed infants [*47]. Arachidonic acid supplementation
is also needed because DHA supplementation given alone lowers arachidonic acid
levels [*48] and because arachidonic acid is essential for growth [*49,*50].
The lipoxygenase eicosanoids of arachidonic acid contribute to the ability
of Nerve Growth Factor (NGF) to increase neurite outgrowth [*51]. Deficiency
of arachidonic acid during brain development is less reversible than
deficiency of DHA [*6].
Evidently an infant's desaturase and elongase enzymes are not fully developed
because no amount of alpha-linolenic acid supplement can provide enough DHA
for neural development [*52]. More recent reviews have firmly recommended the
inclusion of arachidonic acid and DHA in the formula of premature babies [*53].
It seems reasonable to wonder if dietary fat or fat supplements affect
the mental function of adults.
Experiments on rats indicate that manipulation
of dietary fats can alter the fatty acid composition of brain-cell
membranes — with effects on behavior. A diet high in saturated fat was
shown to "impair a wide range of learning and memory functions" [*54]. Soybean
oil has more alpha-linolenic acid than sunflower oil. Soybean-fed
rats have shown significantly better learning and less sensitivity to pain
than safflower-fed rats [*55].
Recent experiments testing relative concentrations of linoleic acid
to alpha-linolenic acid in the range of from 3-to-1 to 6-to-1 verified that
a 4-to-1 ratio is optimal for spatial learning and pain tolerance in
rats [*56].
The influence of essential fatty acid supplement on brain membrane
content declines with maturity, however. Adult cell membrane content of
DHA and arachidonic acid is only slowly altered by diet or supplement. If
dietary intake of essential fatty acid is low, the body will sacrifice
essential fatty acid content of cell membranes outside the brain
before neurons are affected. A study of elderly men, however, showed greater
cognitive impairment among those with a history of high dietary linoleic
acid compared with controls, whereas those with high fish consumption showed
reduced cognitive decline [*57]. One experiment showed promotion of neuron
growth by DHA and inhibition by arachidonic acid [*58]. But an experiment
on adult mice showed that
excessively high supplements of DHA without arachidonic acid supplementation
can impair physical and cognitive performance [*59]. Arachidonic acid
may facilitate LTP-type learning in the hippocampus of the brain [*51].
An experiment studying maze-learning in rats demonstrated that,
after training,
the rats showed less cholesterol and more membrane fluidity in the hippocampal
and cortical regions of the brain [*60]. Adult mice fed fish oil for 12
months showed more brain DHA, less brain arachidonic acid, more synaptic
membrane fluidity and higher maze-learning ability [*61]. Rats fed
perilla oil showed 30% more hippocampal neuron synaptic vesicle density
and improved learning compared to rats fed safflower oil [*62].
Measurements of fatty acid content of brain cell (neuron) membranes
show decreased DHA with aging. Since DHA is particularly concentrated in
synaptic membranes, lowered DHA levels may contribute to declining brain
function. DHA is also reduced when the brains of rats are experimentally
exposed to high oxygen levels — suggesting that free-radical oxidation
is causing the depletion in both cases. Vitamin E treatment protected the
rats from neuron damage from the oxygen. This suggests that
Vitamin E may be important for prevention of neurodegeneration in
humans [*63].
(For more detail about DHA — see my essay
DHA for Hearts and Minds).
Arachidonic acid can be released from cell membranes exposed to
neurotransmitters,
neuromodulators and neurohormones. The
release of arachidonic acid can directly modify neuron excitability by binding with
hydrophobic binding sites of ion channels or can be metabolized to eicosanoids
that ineract with neuronal eicosanoid receptors to have a
second messenger effect.
Arachidonic acid is known to
worsen brain damage during stroke
and other conditions of oxygen depletion. Although
Vitamin E reduces the
toxic effects of arachidonic acid in hypoxic conditions,
N-Acetyl-Cysteine (NAC, a nutrient
which increases glutathione synthesis) completely blocks the arachidonic
acid toxicity. Because NAC is not an effective
anti-oxidant against
superoxide, the arachidonic acid toxicity must be due to lipid
peroxidation [*51].
Since the 1950s it has been believed that schizophrenia is caused
by brain disturbances involving the neurotransmitter dopamine. Recently
it has been observed that many schizophrenics have reduced levels of DHA
and arachidonic acid — and a sizable proportion of these patients do not
flush red on 200 mg doses of niacin. DHA is known to be highly concentrated
in synapses, suggesting that reduced sensitivity to dopamine due to low
levels of DHA and arachidonic acid in dopamine receptors may be a more
fundamental cause of schizophrenia than dopamine deficiency [*64].
As brain cell membranes age, the ratio of cholesterol to phospholipid
increases and membrane fluidity decreases. A similar effect is seen in
brains which are becoming tolerant to ethyl alcohol
(beverage alcohol).
Experiments exposing rats to ethyl alcohol showed
tissue depletion of DHA and arachidonic acid, particularly in the
liver [*65,*66]. Phosphatidylethanolamine in the cerebral
cortex gray matter of the brains of alcoholics show lower levels of DHA
and arachidonic acid [*67]. Methionine (or S-adenosylmethionine, SAM) has
reversed the DHA and arachidonic acid depletion in the liver following
alcohol treatment of rats [*66]. Oxidized DHA and arachidonic acid
enzyme products (isoprostanes and neuroprostanes) are both markedly
eleveated in the cerebrospinal fluid of Alzheimer's Disease patients as compared to age-matched
controls. Lipid peroxidation would be an expected consequence of inflammatory
processes associated with Alzheimer's Disease, but could also be indicative
of oxidation as a cause of the disease.
The low death rate from coronary heart disease among Greenland Eskimos
led scientists to suspect that high fish consumption might be protective.
A 20-year study of 852 middle-age Dutch men showed that coronary
artery disease was more than 50% lower among the men who consumed at least
30 grams of fish per week, when compared with men who did not eat fish [*68].
A 30-year study of over 2,100 Chicago men showed a 62% risk of
coronary heart disease and 56% risk of sudden myocardial infarction for
men who ate at least 35 grams of fish daily, compared to those who ate
none [*69].
Series 3 prostaglandins & thromboxanes inhibit the
release of arachidonic
acid from phospholipids and thus reduce formation of series 2
prostaglandins & thromboxanes. PGI3 is as potent an antiaggregator
as PGI2, whereas TXA3 is a weaker platelet aggregator than
TXA2 — so the series 3 products result in a less net clotting.
TXA2 causes potent vasoconstriction.
Oxidative stress is known to contribute to atherosclerosis, but it is usually
attributed to oxidation of LDL-cholesterol, causing it to adhere to artery walls. Some
oxidative effect is also due to vascular smooth muscle cell proliferation induced by
arachidonic acid derived eicosanoids functioning as transcription factors. The arachidonic
acid lipoxygenase metabolites 12-HPETE and 15-HPETE act as mitogens by increasing
AP-1 (Activator Protein-1) transcription factor
activity [JOURNAL OF BIOLOGICAL CHEMISTRY; Rao,GN; 271(44):27760-27764 (1996)].
Fish oil has been shown to lower LDL-cholesterol by about
13% [*70], to lower blood pressure [*71], and to dramatically lower
blood triglycerides [*72,*73]. The effect on triglycerides,
in particular, appears to be due
to EPA and DHA, because flaxseed (ie, linseed oil, which is over 50%
alpha-linolenic acid) did not lower triglycerides. More careful analysis has
established that DHA alone has no effect on blood triglycerides, but that
EPA alone is capable of lowering blood triglycerides by about 30% [*74].
Purified DHA was shown to lower blood pressure and reduce
blood viscosity. The evidence indicated that DHA increases red blood cell
membrane fluidity, thereby increasing the deformability of the blood cells
so that they can move through capillaries more easily and thus lower
blood viscosity and blood pressure [*75].
High fasting blood insulin concentrations has been determined
to be an independent risk factor for ischemic heart disease [*76].
The fatty acid content of muscle membranes is critical in determining
insulin sensitivity. A high-fat diet can increase insulin resistance,
but both dietary omega−3 and omega−6 fatty acids can increase membrane
fluidity and thereby improve insulin sensitivity [*77].
The protective effect of fish oil against cardiac arrhythmias
(irregular heartbeats) has
been strikingly illustrated by two similar experiments, one performed
on rats [*78]
and the other on marmoset monkeys [*79]. Middle-aged animals were fed
sheep fat (saturated fat), sunflower seed oil (omega−6) or fish oil
(omega−3) for 12 weeks (for rats) or for 24-30 months (for monkeys). With
both rats and monkeys arrhythmia was produced in over 40% of the animals
fed sheep fat, roughly 10% of the animals fed safflower oil and in
none of the animals who were fed fish oil.
Phosphatidylethanolamine from monkey heart tissue showed 5 times
more (over 25% total) DHA in the fish-oil fed
monkeys than in the other two groups. EPA accounted for over 6% of the fatty
acid phosphatidylethanolamine of fish-oil fed monkeys, and was undetectable
in the other two groups. A similar experiment on rats using purified DHA
and purified EPA, rather than fish-oil, indicated that DHA is responsible
for most of the anti-arrhythmic effect [*80]. It is the DHA release from
membrane breakdown, rather than DHA in the bloodstream, which is
protective [*81]. Moreover, DHA in the membrane increases the
efficiency of the heart cyclic-AMP (a cell messenger molecule) [*82].
Although most fish oils are high in EPA and DHA, there are some
fish oils which are not. Flounder, swordfish and sole are particularly low
in EPA and DHA. Fish oils having the highest levels of EPA and DHA include
mackerel, herring and salmon. Some fish, such as cod and haddock, store
most of their fat in the liver, therefore the liver oils of these fish
should be taken rather than the fillet.
Increased fish oil consumption, however, is associated with increased
lipid peroxidation in heart, liver and lung tissue — moreso than in the
brain [*83]. Again, Vitamin E has been recommended for those who have a
high fish oil consumption to reduce lipid peroxidation [*84]. In some
cases, consumption of fish can harmful due to high levels of mercury
(for more detail about mercury risk — see my essay
Is Mercury in Fish a Health Hazard?).
Lipid peroxidation of LDL cholesterol is believed to initiate arterial wall injury
and facilitate the formation of atherosclerotic foam cells. Leucocytes & endothelial
cells may contribute to atherosclerosis through inflammation induced by
5-lipoxygenase [PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES (USA)
100(3):1238-1248 (2003)].
(For more details concerning cardiovascular
disease, risk factors and prevention — see my essays
Sudden Cardiovascular Death and
Prevention of Cardiovascular Disease.)
In the face of all the data, there remains the question "What
omega−3 and omega−6 fatty acids should be included in the diet, and in
what quantities & proportions?" One standard which is not of much use
in this case is the amount of essential fatty acid intake below which a
deficiency disease occurs. It is very difficult to produce a deficiency
disease of essential fatty acid in normal adults, even in the poorest of
diets. The important question is "What levels of essential fatty acids
provide optimum health?" This question still results in considerable
controversy among nutritionists.
Deficiency disease results from diets where linoleic acid is less
than 1% of total calories. Governmental agencies of various nations
(including the World Health Organization) recommend an omega−6 intake
of 1-3% of total calories, increased to 3-6% during pregnancy and
lactation. Since deficiency disease symptoms have not been unquestionably
demonstrated for the omega−3 fatty acids (DHA, EPA and alpha-linolenic acid)
there is controversy about how much to recommend or whether to recommend
omega−3 supplementation at all [*85]. Ironically, the avidity
with which enzymes preferentially utilize omega−3 fatty acids could
misleadingly make it appear that omega−6 is more essential.
When stated, omega−3
recommendations are often given in relation to omega−6 intake, due to
the enzyme competition between the two fatty acid families.
The same enzymes that produce the omega−6 products from linoleic
acid also operate to produce the omega−3 products from alpha-linolenic acid.
The competition for these enzymes by omega−6 and omega−3 fatty acids is
unequal, however. Alpha-linolenic acid at 0.5% of calories can suppress
arachidonic acid production to the same degree as linoleic acid at 7% of
calories can suppress DHA production. Nonetheless, a 14-to-1 ratio of
omega−6 to omega−3 is not necessarily optimal.
A 4-to-1 ratio has been cited as optimal in a brain function
experiment [*56], whereas another experiment showed 2-to-1 is the best ratio
for immune function [*23]. A 5-to-1 ratio has been recommended on the
basis of the ratio
of omega−6 to omega−3 in human milk. But 5-to-1 is probably just a reflection
of the dietary intake of contemporary mothers. The content of DHA and EPA in
human milk has been increased experimentally by giving fish oil supplements
to lactating women [*86].
Some advocates of "a return to natural levels" of fatty
acid intake recommend dietary ratios of 1-to-1.
Up until about 200 years ago, the human diet contained much
higher levels of omega−3 fatty acids. The meat of wild animals that
forage for food is rich in EPA, unlike the meat of domesticated animals
that have been fattened with grains. High levels of dietary omega−6
vegetable oils are a modern phenomenon. EPA competes with arachidonic acid
for the cyclo-oxygenase enzyme, reducing the production of
thromboxane A2, the most powerful platelet
aggregating agent known. Some people feel that restoration of the
historic omega−3/omega−6 ratios is a more "natural" way of
preventing heart attack
than using aspirin to irreversibly
inactivate cyclo-oxygenase [*15]. Aspirin, even in normal therapeutic doses,
can produce dizziness, migraine headaches, depression, anxiety,
and stomach irritation or stomach bleeding [*87].
The high levels of omega−6 fatty acids in modern diets may even
adversely affect omega−3 utilization by cellular mechanisms that reduce
desaturase formation [*88]. Rats on a perilla oil diet which results in
omega−6 to omega−3 ratios of approximately 1-to-4 showed the longest
lifespans. Eskimos have low heart and autoimmune disease on a fish oil
diet that gives a 1-to-3 ratio [*6]. Concern that the anti-clotting
effect of fish oil might lead to increased incidence of stroke are
apparently unfounded, since stroke is primarily the result of high
blood pressure and weakened blood vessels.
It would seem prudent to reduce fat intake of nonessential
fats to as low a quantity as possible, so long as absorption of
oil-soluble vitamins is not impaired. Dietary fat could mainly
consist of essential fats.
The value of EPA or DHA to prevent serious heart problems should be
enough to encourage anyone to
take an amount of these nutrients up to 1% of total calories. For a
person on a 2,500 calorie daily diet, this would mean 5 to 7.5 grams
of essential fatty acids per day with perhaps 500 mg each of EPA and DHA.
But too much EPA and DHA can be harmful.
When fish oil supplies up to 12% of calories, both
the brain and the liver show arachidonic acid deficiencies [*48].
The same effect would probably be seen with excessive amounts of
other omega−3 supplements, like linseed or perilla oil.
It would be nice to have a single essential fatty
acid formulation that optimizes benefits to the heart, the brain
and the immune system for people of all ages, but this is probably
unrealistic. Since DHA is responsible for
most of the omega−3 benefits to the brain and the omega−3 prevention
of heart arrhythmia — while avoiding most of the immune-system
depression due to EPA — omega−3 formulations that are higher in DHA rather
than EPA should be preferred. For people who dislike fish oil, especially
young people with healthy immune systems
and functioning desaturase enzymes, perilla oil or linseed oil may be
adequate to obtain a better balance between omega−6 and omega−3. Nonetheless,
only about a fifth of alpha-linolenic acid is normally converted to
DHA and EPA, partially because the body more readily burns unsaturated
fats for energy than saturated fats [*6].
But for the very elderly, immune function might be the paramount
consideration. Biomarkers of
immune function were shown to be a very good predictor of the 2-year
survival of 102 elderly people between the ages of 86 and 92 [*89].
A normally mild disease can be fatal to a person with a weakened
immune system. One lifespan study on rats showed reduced lifespan
on rats fed fish oil [*90], possibly due to immune suppression by
EPA. But rats are unlike humans in that they rarely die of
cardiovascular disease and they have a lower capacity to synthesize
the protective eicosanoid Prostacyclin (PCI3) from EPA.
Other experiments, on mice, have shown extended lifespan with
fish-oil. Fish oil even increased the life-extending benefits of
calorie restriction on the mice [*91].
GLA supplements like evening primrose oil, or borage oil, might
seem undesirable for normal people because of the danger that they would
increase arachidonic acid. But studies have shown an increase in
membrane DGLA and series 1 eicosanoids, with beneficial anti-inflammatory
consequences [*92]. GLA can also lower blood pressure [*93].
To minimize lipid peroxidation,
essential fatty acid supplements should be taken
with no less than 500 mg of Vitamin E per day. Both gamma and alpha
forms of tocopherol should be included [*94] for effectiveness.
Vitamin E is an antioxidant which strongly prevents membrane
peroxidation. The combination of Vitamin E and omega−3 fatty acid
can reduce cancer risk while protecting heart cell membranes,
brain cell membranes, immune-cell membranes and the receptor membranes
that allow hormones to act. Vitamin E can protect essential fatty acids
from lipid peroxidation in capsules and in the bloodstream, as well
as in cell membranes. But for smokers, vitamin E may not be adequate
to reduce oxidation of fish oil in LDL-cholesterol, and some medical
authorities have cautioned against too much fish oil consumption by
smokers [*95].
Ideally, essential fatty acids and Vitamin E
should be formulated together in an air-tight capsule. Vitamin C helps
maintain the antioxidant capabilities of Vitamin E. Boosting glutathione
levels with N-acetyl-cysteine (NAC) and the use of other antioxidant
nutrients can further protect against lipid peroxidation of essential
fats. Glutathione not only regenerates both Vitamin E and Vitamin C that
has been oxidized, it prevents formation of deadly hydroxyl free-radicals.
Optimum dietary benefit from fat for most people would come
from a program of reduced total fat, reduced saturated and unessential
fat, and increased proportions of omega−3 (relative to omega−6)
essential fats. A high omega−3 oil like perilla oil might be a simple
remedy for young people — and the best remedy for smokers. But as most
people age, they will benefit most from CLA, GLA, and DHA supplementation
combined with antioxidants (especially vitamin E) to protect these
polyunsaturated essential fats from oxidation.
Fats are an important component of membranes in our hearts,
brains, immune cells and most of the other tissues of our bodies. Since
we need these fats, it is important to ensure that we have the right
kind of fats, that we have enough of them and that we protect them
with antioxidants.
Normal F-Ring Prostaglandin F2-isoprostanes
VI. FATS FOR IMMUNITY
VII. FATS AGAINST CANCER
VIII. FATS AGAINST DIABETES AND THE EFFECTS OF ALCOHOLISM
IX. FATS FOR THE BRAIN
X. FATS FOR THE HEART
XI. GETTING THE BEST FAT NUTRITION
XII. CONCLUSIONS
XIII. FOOTNOTES
. Engler
SOME OTHER ON-LINE REFERENCES